Page last updated: 2024-08-21

thiazoles and Anochlesia

thiazoles has been researched along with Anochlesia in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19902 (9.52)18.7374
1990's11 (52.38)18.2507
2000's5 (23.81)29.6817
2010's3 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agrawal, S; Kumari, N; Luthra, PM1
Alam, MM; Anwer, T; Azam, F; Barodia, SK1
Auclair, AL; Barret-Grévoz, C; Barreto, M; Depoortère, R; Kleven, MS; Newman-Tancredi, A1
Enzensperger, C; Fleck, C; Lehmann, J; Mueller, FK; Robaa, D; Schulze, M; Siol, O1
Azam, F; Mohan, G; Prasad, MV; Shrivastava, AK; Thangavel, N1
Chaki, S; Funakoshi, T; Goto, M; Kameo, K; Kawashima, N; Kumagai, T; Nakazato, A; Okuyama, S; Suzuki, Y; Yoshikawa, R1
Konieczny, J; Ossowska, K; Pilc, A; Wolfarth, S1
Cenci, MA; Danysz, W; Dekundy, A; Pietraszek, M; Schaefer, D1
Guanowsky, V; Howard, HR; Lebel, LA; Lowe, JA; McLean, S; Schmidt, AW; Schulz, DW; Seeger, TF; Seymour, PA; Zorn, SH1
Ikeda, K; Ishibashi, T; Ishida, K; Nakamura, M; Ohno, Y; Okada, K1
Cooper, BR; Navas, F; Norman, MH; Rigdon, GC1
Ewing, FE; Furman, JS; Howard, HR; Jackson, E; Johnson, C; Lowe, JA; Maloney, PR; Morrone, J; Newman, ME; Robinson, GL; Schmidt, AW; Seeger, TF; Seymour, PA; Zorn, SH1
Antoku, F; Ishizumi, K; Kojima, A; Saji, I; Yoshigi, M1
Kołodziejczyk, K; Maj, J; Rogóz, Z; Skuza, G1
Chaki, S; Ikeda, Y; Imagawa, Y; Kawashima, N; Kumagai, T; Nagamine, M; Nakazato, A; Ogawa, S; Okuyama, S; Suzuki, Y; Tomisawa, K; Yoshikawa, R1
Caignard, DH; Depreux, P; Diouf, O; Guardiola-Lemaître, B; Lesieur, D; Pfeiffer, B; Poupaert, JH; Renard, P; Rettori, MC; Taverne, T1
Chaki, S; Funakoshi, T; Ikeda, Y; Kawashima, N; Kumagai, T; Nagamine, M; Nakazato, A; Ogawa, SI; Okuyama, S; Suzuki, Y; Tomisawa, K; Yoshikawa, R1
Dunn, RW; Errico, CL; Hrib, NJ; Huger, FP; Jurcak, JG1
Hirose, A; Kato, T; Katsube, J; Nakamura, M; Ohno, Y; Shimizu, H; Tanaka, H1
Koek, W; Woods, JH1
Catt, JD; Eison, MS; Lobeck, WG; Minielli, JL; New, JS; Riblet, LA; Smith, DW; Taylor, DP; Temple, DL; Yevich, JP1

Other Studies

21 other study(ies) available for thiazoles and Anochlesia

ArticleYear
Pharmacological assessments of potent A
    Neuroscience letters, 2017, 04-24, Volume: 647

    Topics: Adenosine A2 Receptor Antagonists; Adenosine-5'-(N-ethylcarboxamide); Animals; Antiparkinson Agents; Catalepsy; Female; Haloperidol; Male; Mice; Motor Activity; Parkinson Disease; Rats, Wistar; Receptor, Adenosine A2A; Thiazoles; Toxicity Tests, Acute; Toxicity Tests, Subacute; Urea

2017
Neuroprotective effect of naphtha[1,2-d]thiazol-2-amine in an animal model of Parkinson's disease.
    Journal of enzyme inhibition and medicinal chemistry, 2009, Volume: 24, Issue:3

    Topics: Animals; Antioxidants; Brain; Catalepsy; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Glutathione Peroxidase; Haloperidol; Male; Malondialdehyde; Mice; Naphthalenes; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Superoxide Dismutase; Thiazoles

2009
Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys.
    Behavioural brain research, 2009, Nov-05, Volume: 203, Issue:2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Aripiprazole; Benzamides; Benzodiazepines; Benzoxazoles; Catalepsy; Clozapine; Dibenzothiazepines; Dioxanes; Dopamine Antagonists; Female; Haloperidol; Macaca fascicularis; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Remoxipride; Risperidone; Serotonin Receptor Agonists; Thiazoles; Tropanes; Video Recording

2009
Molecular combination of the dopamine and serotonin scaffolds yield in novel antipsychotic drug candidates - characterization by in vivo experiments.
    Arzneimittel-Forschung, 2012, Volume: 62, Issue:5

    Topics: Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Biological Availability; Calcium; Catalepsy; Cells, Cultured; Dopamine; Female; Haloperidol; Humans; Motor Activity; Neuroglia; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Serotonin; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles

2012
Structure-based design, synthesis and molecular modeling studies of thiazolyl urea derivatives as novel anti-parkinsonian agents.
    Medicinal chemistry (Shariqah (United Arab Emirates)), 2012, Volume: 8, Issue:6

    Topics: Animals; Antiparkinson Agents; Catalepsy; Chemistry Techniques, Synthetic; Drug Design; Haloperidol; Humans; Male; Mice; Molecular Docking Simulation; Oxidative Stress; Protein Conformation; Receptors, Adenosine A2; Thiazoles; Urea

2012
In vitro and in vivo pharmacological profile of 5-[2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl]-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562), a novel and putative atypical antipsychotic.
    Life sciences, 2002, Aug-09, Volume: 71, Issue:12

    Topics: Animals; Antipsychotic Agents; Behavior, Animal; Catalepsy; Central Nervous System Stimulants; Clozapine; Humans; Male; Methamphetamine; Motor Activity; Piperidines; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-1; Receptors, Dopamine; Receptors, Drug; Receptors, Serotonin; Risperidone; Stereotyped Behavior; Thiazoles

2002
MTEP, a new selective antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5), produces antiparkinsonian-like effects in rats.
    Neuropharmacology, 2005, Volume: 49, Issue:4

    Topics: Animals; Antiparkinson Agents; Catalepsy; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electromyography; Haloperidol; Male; Movement; Muscle, Skeletal; Parkinsonian Disorders; Pyridines; Rats; Rats, Wistar; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Thiazoles; Time Factors

2005
Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease.
    Brain research bulletin, 2006, Apr-14, Volume: 69, Issue:3

    Topics: Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Catalepsy; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesias; Functional Laterality; Haloperidol; Levodopa; Male; Motor Activity; Oxidopamine; Parkinson Disease; Pyridines; Quinolines; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Rotarod Performance Test; Thiazoles; Time Factors

2006
Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 275, Issue:1

    Topics: Adenylyl Cyclases; Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Biogenic Monoamines; Brain; Catalepsy; Cattle; CHO Cells; Choroid Plexus; Cricetinae; Cyclic AMP; Dopamine Antagonists; Guinea Pigs; Humans; Male; Mice; Mice, Inbred Strains; Motor Activity; Neurotransmitter Uptake Inhibitors; Piperazines; Quipazine; Rats; Receptors, Adrenergic; Receptors, Dopamine; Receptors, Serotonin; Serotonin Antagonists; Swine; Thiazoles

1995
Evaluation of bradykinesia induction by SM-9018, a novel 5-HT2 and D2 receptor antagonist, using the mouse pole test.
    Pharmacology, biochemistry, and behavior, 1994, Volume: 49, Issue:1

    Topics: Animals; Antipsychotic Agents; Catalepsy; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Indoles; Isoindoles; Male; Mice; Mice, Inbred Strains; Psychomotor Performance; Serotonin Antagonists; Thiazoles

1994
Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents.
    Journal of medicinal chemistry, 1994, Aug-05, Volume: 37, Issue:16

    Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Binding, Competitive; Catalepsy; Corpus Striatum; Cyclization; Dopamine D2 Receptor Antagonists; Frontal Lobe; Hippocampus; Indoles; Isoindoles; Male; Mice; Molecular Structure; Motor Activity; Phthalazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship; Thiazoles

1994
3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents.
    Journal of medicinal chemistry, 1996, Jan-05, Volume: 39, Issue:1

    Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Brain; Catalepsy; Clozapine; Dopamine; Drug Design; Humans; Molecular Structure; Phosphatidylinositols; Piperazines; Prazosin; Rats; Receptors, Adrenergic; Receptors, Dopamine; Serotonin Antagonists; Thiazoles

1996
Succinimide derivatives. II. Synthesis and antipsychotic activity of N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-1,2-cis- cyclohexanedicarboximide (SM-9018) and related compounds.
    Chemical & pharmaceutical bulletin, 1995, Volume: 43, Issue:12

    Topics: Animals; Antipsychotic Agents; Behavior, Animal; Catalepsy; Central Nervous System Depressants; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; In Vitro Techniques; Indoles; Isoindoles; Mice; Motor Activity; Neostriatum; Psychotropic Drugs; Rats; Serotonin Antagonists; Spiro Compounds; Stereotyped Behavior; Structure-Activity Relationship; Succinimides; Thiazoles

1995
The behavioural effects of pramipexole, a novel dopamine receptor agonist.
    European journal of pharmacology, 1997, Apr-11, Volume: 324, Issue:1

    Topics: Animals; Antiparkinson Agents; Benzazepines; Benzothiazoles; Body Temperature; Catalepsy; Clozapine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Haloperidol; Injections, Subcutaneous; Levodopa; Male; Mice; Motor Activity; Pramipexole; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Spiperone; Stereotyped Behavior; Sulpiride; Thiazoles

1997
In vitro and in vivo characterization of the dopamine D4 receptor, serotonin 5-HT2A receptor and alpha-1 adrenoceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl]thiazole (NRA0045).
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 282, Issue:1

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Catalepsy; COS Cells; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Male; Mice; Mice, Inbred ICR; Motor Activity; Norepinephrine; Pyrrolidines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D4; Receptors, Serotonin; Serotonin Antagonists; Stereotyped Behavior; Thiazoles

1997
Novel benzothiazolin-2-one and benzoxazin-3-one arylpiperazine derivatives with mixed 5HT1A/D2 affinity as potential atypical antipsychotics.
    Journal of medicinal chemistry, 1998, Jun-04, Volume: 41, Issue:12

    Topics: Animals; Antipsychotic Agents; Avoidance Learning; Catalepsy; Cattle; Corpus Striatum; Dopamine Agents; Frontal Lobe; Hippocampus; Hyperkinesis; Mice; Oxazines; Piperazines; Rabbits; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Agents; Sleep; Stereotyped Behavior; Structure-Activity Relationship; Swine; Thiazoles

1998
A selective dopamine D4 receptor antagonist, NRA0160: a preclinical neuropharmacological profile.
    Life sciences, 1999, Volume: 65, Issue:20

    Topics: Animals; Antipsychotic Agents; Behavior, Animal; Brain; Catalepsy; Clozapine; Dopamine D2 Receptor Antagonists; Drug Evaluation, Preclinical; Locomotion; Male; Maze Learning; Methamphetamine; Mice; Mice, Inbred ICR; Piperidines; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D4; Reflex, Startle; Stereotyped Behavior; Swimming; Thiazoles

1999
Synthesis and biological evaluation of a series of substituted N-alkoxyimides and -amides as potential atypical antipsychotic agents.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:3

    Topics: Amides; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Catalepsy; Chemical Phenomena; Chemistry; Drug Evaluation, Preclinical; Imides; Male; Mice; Molecular Structure; Motor Activity; Phthalimides; Piperazines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Serotonin; Self Stimulation; Social Behavior; Spiro Compounds; Stereotyped Behavior; Thiazoles

1991
Pharmacological actions of SM-9018, a new neuroleptic drug with both potent 5-hydroxytryptamine2 and dopamine2 antagonistic actions.
    Japanese journal of pharmacology, 1990, Volume: 53, Issue:3

    Topics: Animals; Antipsychotic Agents; Behavior, Animal; Brain Chemistry; Catalepsy; Dopamine Antagonists; Indoles; Isoindoles; Ketanserin; Male; Methamphetamine; Mice; Mice, Inbred Strains; Motor Activity; Norepinephrine; Parasympatholytics; Psychomotor Performance; Rats; Rats, Inbred Strains; Serotonin Antagonists; Spiperone; Stereotyped Behavior; Thiazoles

1990
2-Amino-6-trifluoromethoxy benzothiazole (PK 26124), a proposed antagonist of excitatory amino acid neurotransmission, does not produce phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
    Neuropharmacology, 1988, Volume: 27, Issue:7

    Topics: Animals; Behavior, Animal; Catalepsy; Columbidae; Discrimination Learning; Macaca mulatta; Male; Mephenesin; Phencyclidine; Rats; Rats, Inbred Strains; Riluzole; Species Specificity; Synaptic Transmission; Thiazoles

1988
Synthesis and biological evaluation of 1-(1,2-benzisothiazol-3-yl)- and (1,2-benzisoxazol-3-yl)piperazine derivatives as potential antipsychotic agents.
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:3

    Topics: Animals; Antipsychotic Agents; Avoidance Learning; Binding, Competitive; Catalepsy; Cerebral Cortex; Corpus Striatum; Isoxazoles; Male; Models, Molecular; Norepinephrine; Oxazoles; Physostigmine; Piperazines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Serotonin; Sleep; Spiro Compounds; Stereotyped Behavior; Structure-Activity Relationship; Thiazoles

1986